title: Hypertensive rebound after angiotensin converting enzyme inhibitor withdrawal in diabetic patients with chronic renal failure.
authors.forename: G B
authors.initials: GB
authors.lastname: Piccoli
authors.forename: P
authors.initials: P
authors.lastname: Anania
authors.forename: L
authors.initials: L
authors.lastname: Biancone
authors.forename: E
authors.initials: E
authors.lastname: Mezza
authors.forename: M
authors.initials: M
authors.lastname: Vischi
authors.forename: A
authors.initials: A
authors.lastname: Jeantet
authors.forename: C
authors.initials: C
authors.lastname: Rabbia
authors.forename: D
authors.initials: D
authors.lastname: Savio
authors.forename: D
authors.initials: D
authors.lastname: Rossatto
authors.forename: M
authors.initials: M
authors.lastname: Gai
authors.forename: P C
authors.initials: PC
authors.lastname: Perin
authors.forename: G P
authors.initials: GP
authors.lastname: Segoloni
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1; D003925:Diabetic Angiopathies / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004656:Enalapril / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril